Targeting Alternative Sites on the Androgen Receptor to Treat Castration-Resistant Prostate Cancer

Recurrent, metastatic prostate cancer continues to be a leading cause of cancer-death in men. The androgen receptor (AR) is a modular, ligand-inducible transcription factor that regulates the expression of genes that can drive the progression of this disease, and as a consequence, this receptor is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lallous, Nada, Dalal, Kush, Cherkasov, Artem, Rennie, Paul S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709796/
https://www.ncbi.nlm.nih.gov/pubmed/23771019
http://dx.doi.org/10.3390/ijms140612496

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709796/
https://www.ncbi.nlm.nih.gov/pubmed/23771019
http://dx.doi.org/10.3390/ijms140612496

Ejemplares similares